Skip to main navigation Skip to search Skip to main content

Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis

Tino Prell*, Thomas Peschel, Viktor Hartung, Joern Kaufmann, Ribanna Klauschies, Nils Bodammer, Katja Kollewe, Reinhard Dengler, Julian Grosskreutz

*Corresponding author for this work

Abstract

Background: Amyotrophic lateral sclerosis (ALS) is characterized by pronounced clinical heterogeneity in terms of onset and disease progression. Widespread changes in white matter fibres could be observed by diffusion tensor imaging (DTI), which detects alterations in the degree (diffusivity, ADC) and directedness (fractional anisotropy, FA) of proton movement. The aim of the current study was to determine whether different ALS onset types were reflected in different DTI brain patterns. Methods: Seventeen patients with a diagnosis of ALS (6 bulbar, 11 limb onset) and seventeen age-matched controls received 1.5T DTI, where FA and ADC were analyzed using statistical parametric mapping. Results: In ALS patients, an increased diffusivity in the white matter was found below the precentral gyrus and along the corticospinal tract (CST) right into the internal capsule. The FA was decreased in the posterior limb of internal capsule and in the subcortical white matter in the precentral gyrus. In bulbar onset increased diffusivity was found in the CST, whilst in limb onset, frontal subcortical areas displayed an increased diffusivity. Conclusion: DTI changes can be regarded as prominent features in ALS. Herein we were able to demonstrate discriminating brain DTI patterns due to bulbar or limb onset.

Original languageEnglish
JournalClinical Neurology and Neurosurgery
Volume115
Issue number8
Pages (from-to)1281-1287
Number of pages7
ISSN0303-8467
DOIs
Publication statusPublished - 08.2013
Externally publishedYes

Funding

Tino Prell, Thomas Peschel, Viktor Hartung, Joern Kaufmann, Ribanna Klauschies, Nils Bodammer, Katja Kollewe, Julian Grosskreutz report no disclosures. Reinhard Dengler reports no disclosures in regard to the current study. RD received honoraria, research grants and travel grants from PharmAllergan , Ipsen Pharma , Merz Pharma , Boehringer-Ingelheim and Bayer Health Care .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Centers: Center for Neuromuscular Diseases

Cite this